Guidelines

NCPA board member urges House Subcommittee to eliminate “gag clauses”
In testimony before the House Energy and Commerce Subcommittee on Health, a pharmacist representing NCPA urged support of legislation to prohibit gag clauses that may result in patients being overcharged for medications.
FDA approves ITF Pharma’s Tiglutik for ALS
IFT Pharma's Tiglutik is the first easy-to-swallow thickened riluzole liquid for ALS, the company said.

FDA gives Merck the green light for two new HIV drugs

Merck's Delstrigo and Pifeltro HIV medicines have received approval from the Food and Drug Administration.
AAP issues flu vaccine recommendations for 2018-2019

The American Academy of Pediatrics recommends that all children should receive the flu shot as soon as it is available.
AAM to FDA: support measures to improve biosimilar competition

The Association for Accessible Medicines is calling on the Food and Drug Administration to support stronger policies that encourage biosimilar market growth.
AMCP calls on FDA to finalize guidance on biosimilar interchangeability

The Academy of Managed Care is urging the Food and Drug Administration to issue its final guidance on biosimilar interchangeability standards and to provide education on substituting interchangeable products.
QS/1 selected as early adopter in new CMS script standard

QS/1 is partnering with Surescripts to adopt the Centers for Medicare and Medicaid Services’ new standard for e-prescriptions.
Counter Talk: Hope for community pharmacy

Ed Vess discusses how state efforts make it easier to bill some payers as federal provider status lags.
FDA approves Lupin’s generic potassium chloride oral solution

Lupin has received the FDA’s green light for a generic version of Genus’ potassium chloride oral solution in two dosage strengths.
Amneal partners with American Regent for generic Makena

Amneal and American Regent have reached a five-year deal for generic Makena, an injectable intended to reduce preterm births in women.

NCPA board member urges House Subcommittee to eliminate “gag clauses”

FDA approves ITF Pharma’s Tiglutik for ALS

FDA gives Merck the green light for two new HIV drugs

AAP issues flu vaccine recommendations for 2018-2019

AAM to FDA: support measures to improve biosimilar competition

AMCP calls on FDA to finalize guidance on biosimilar interchangeability

QS/1 selected as early adopter in new CMS script standard

Counter Talk: Hope for community pharmacy

FDA approves Lupin’s generic potassium chloride oral solution

Amneal partners with American Regent for generic Makena